Oxfordshire Clinical Commissioning Group
Formulary
 
back
7 Obstetrics, Gynaecology, and urinary-tract disorders
07-03-02-02 Parenteral progestogen-only contraceptives

Etonorgestrel Nexplanon®
Formulary

Provides contraception for up to 3 years. 

APCO September 2010. 


MHRA/CHM advice (June 2016):

There have been rare reports of Nexplanon® implants reaching the lung via the pulmonary artery. An implant that cannot be palpated at its insertion site should be located and removed as soon as possible; if unable to locate implant within the arm, the MHRA recommends using chest imaging. Correct subdermal insertion reduces the risk of these events.

Link  MHRA: Reports of implant device in vasculature and lung
 

Green View adult BNF  View SPC online  View childrens BNF
Medroxyprogesterone Acetate Depo-Provera®
Formulary

Intramuscular injection.


Green View adult BNF  View SPC online  View childrens BNF
Medroxyprogesterone acetate Sayana Press®
Formulary

Subcutaneous injection.


Green View adult BNF  View SPC online  View childrens BNF
Etonorgestrel Implanon®
Non Formulary

Discontinued in October 2010 and replaced by Nexplanon®, but some women may have the implant in place until 2013.


View adult BNF  View SPC online  View childrens BNF
Norethisterone enantate Noristerat®
Non Formulary

Provides contraception for 8 weeks; it is used as short-term interim contraception e.g. before vasectomy becomes effective.


View adult BNF  View SPC online  View childrens BNF